259 related articles for article (PubMed ID: 32357493)
1. Novel Insights into PARK7 (DJ-1), a Potential Anti-Cancer Therapeutic Target, and Implications for Cancer Progression.
Jin W
J Clin Med; 2020 Apr; 9(5):. PubMed ID: 32357493
[TBL] [Abstract][Full Text] [Related]
2. PARK7/DJ-1 as a Therapeutic Target in Gut-Brain Axis Diseases.
Pap D; Veres-Székely A; Szebeni B; Vannay Á
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743072
[TBL] [Abstract][Full Text] [Related]
3. DJ-1/PARK7: A New Therapeutic Target for Neurodegenerative Disorders.
Hijioka M; Inden M; Yanagisawa D; Kitamura Y
Biol Pharm Bull; 2017; 40(5):548-552. PubMed ID: 28458339
[TBL] [Abstract][Full Text] [Related]
4. Linking DJ-1 to neurodegeneration offers novel insights for understanding the pathogenesis of Parkinson's disease.
Bonifati V; Oostra BA; Heutink P
J Mol Med (Berl); 2004 Mar; 82(3):163-74. PubMed ID: 14712351
[TBL] [Abstract][Full Text] [Related]
5. 6-Hydroxydopamine induces secretion of PARK7/DJ-1 via autophagy-based unconventional secretory pathway.
Urano Y; Mori C; Fuji A; Konno K; Yamamoto T; Yashirogi S; Ando M; Saito Y; Noguchi N
Autophagy; 2018; 14(11):1943-1958. PubMed ID: 30112966
[TBL] [Abstract][Full Text] [Related]
6. The antioxidant protein PARK7 plays an important role in cell resistance to Cisplatin-induced apoptosis in case of clear cell renal cell carcinoma.
Trivedi R; Dihazi GH; Eltoweissy M; Mishra DP; Mueller GA; Dihazi H
Eur J Pharmacol; 2016 Aug; 784():99-110. PubMed ID: 27112662
[TBL] [Abstract][Full Text] [Related]
7. Impact of Single Amino Acid Substitutions in Parkinsonism-Associated Deglycase-PARK7 and Their Association with Parkinson's Disease.
Anjum F; Joshia N; Mohammad T; Shafie A; Alhumaydhi FA; Aljasir MA; Shahwan MJS; Abdullaev B; Adnan M; Elasbali AM; Pasupuleti VR; Hassan MI
J Pers Med; 2022 Feb; 12(2):. PubMed ID: 35207708
[TBL] [Abstract][Full Text] [Related]
8. DJ-1 promotes osteosarcoma progression through activating CDK4/RB/E2F1 signaling pathway.
Han Z; Wang L; Wang D; Zhang L; Bi Y; Zheng X; Liu W; Bai G; Wang Z; Wan W; Ma Y; Cai X; Liu T; Jia Q
Front Oncol; 2022; 12():1036401. PubMed ID: 36408174
[TBL] [Abstract][Full Text] [Related]
9. DJ-1/park7 protects against neointimal formation via the inhibition of vascular smooth muscle cell growth.
Won KJ; Jung SH; Lee CK; Na HR; Lee KP; Lee DY; Park ES; Choi WS; Shim SB; Kim B
Cardiovasc Res; 2013 Mar; 97(3):553-61. PubMed ID: 23230227
[TBL] [Abstract][Full Text] [Related]
10. DJ-1 modulates the unfolded protein response and cell death via upregulation of ATF4 following ER stress.
Yang J; Kim KS; Iyirhiaro GO; Marcogliese PC; Callaghan SM; Qu D; Kim WJ; Slack RS; Park DS
Cell Death Dis; 2019 Feb; 10(2):135. PubMed ID: 30755590
[TBL] [Abstract][Full Text] [Related]
11. Porcine DJ-1: cloning of PARK7 cDNA, sequence comparison, expression analysis and chromosomal localization.
Larsen K; Madsen LB; Høj A; Bendixen C
Cytogenet Genome Res; 2007; 116(1-2):93-9. PubMed ID: 17268184
[TBL] [Abstract][Full Text] [Related]
12. Chemical Toolkit for PARK7: Potent, Selective, and High-Throughput.
Jia Y; Kim RQ; Kooij R; Ovaa H; Sapmaz A; Geurink PP
J Med Chem; 2022 Oct; 65(19):13288-13304. PubMed ID: 36149939
[TBL] [Abstract][Full Text] [Related]
13. DJ-1 and prevention of oxidative stress in Parkinson's disease and other age-related disorders.
Kahle PJ; Waak J; Gasser T
Free Radic Biol Med; 2009 Nov; 47(10):1354-61. PubMed ID: 19686841
[TBL] [Abstract][Full Text] [Related]
14. DJ-1 linked parkinsonism (PARK7) is associated with Lewy body pathology.
Taipa R; Pereira C; Reis I; Alonso I; Bastos-Lima A; Melo-Pires M; Magalhães M
Brain; 2016 Jun; 139(Pt 6):1680-7. PubMed ID: 27085187
[TBL] [Abstract][Full Text] [Related]
15. DJ-1 as a Biomarker of Parkinson's Disease.
Saito Y
Adv Exp Med Biol; 2017; 1037():149-171. PubMed ID: 29147908
[TBL] [Abstract][Full Text] [Related]
16. Novel association of DJ-1 with HER3 potentiates HER3 activation and signaling in cancer.
Zhang S; Mukherjee S; Fan X; Salameh A; Mujoo K; Huang Z; Li L; To'a Salazar G; Zhang N; An Z
Oncotarget; 2016 Oct; 7(40):65758-65769. PubMed ID: 27582551
[TBL] [Abstract][Full Text] [Related]
17. Protocatechuic acid-mediated DJ-1/PARK7 activation followed by PI3K/mTOR signaling pathway activation as a novel mechanism for protection against ketoprofen-induced oxidative damage in the gastrointestinal mucosa.
Cheng YT; Lin JA; Jhang JJ; Yen GC
Free Radic Biol Med; 2019 Jan; 130():35-47. PubMed ID: 30326282
[TBL] [Abstract][Full Text] [Related]
18. DJ-1/park7 modulates vasorelaxation and blood pressure via epigenetic modification of endothelial nitric oxide synthase.
Won KJ; Jung SH; Jung SH; Lee KP; Lee HM; Lee DY; Park ES; Kim J; Kim B
Cardiovasc Res; 2014 Mar; 101(3):473-81. PubMed ID: 24323315
[TBL] [Abstract][Full Text] [Related]
19. The role of DJ-1 in the pathogenesis of Parkinson's disease.
Wang ZQ; Zhou HY; Chen SD
Neurosci Bull; 2006 Jul; 22(4):232-4. PubMed ID: 17704838
[TBL] [Abstract][Full Text] [Related]
20. Elevated levels of 8-OHdG and PARK7/DJ-1 in peri-implantitis mucosa.
Kasnak G; Firatli E; Könönen E; Olgac V; Zeidán-Chuliá F; Gursoy UK
Clin Implant Dent Relat Res; 2018 Aug; 20(4):574-582. PubMed ID: 29787640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
